Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry

Thumbnail
Fulltext:
312310.pdf
Size:
698.0Kb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2024
Author(s)
Ozkan, A.
Kapiteijn, E.
Bos, F. van den
Aarts, M.J.B.
Berkmortel, F.W.P.J. van den
Blank, C.U.
Boers-Sonderen, M.J.
Bonenkamp, J.J.
Portielje, J.E.
Glas, N.A. de
Source
European Journal of Cancer, 212, (2024), article 115056
ISSN
DOI
Publication type
Article / Letter to editor
If a DOI or any other persistent identifier is unavailable, please use the following repository identifier to link to this item: https://hdl.handle.net/2066/312310   https://hdl.handle.net/2066/312310
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.